Login / Signup

Molecular Camouflage of Plasmodium falciparum Merozoites by Binding of Host Vitronectin to P47 Fragment of SERA5.

Takahiro TouganJyotheeswara R EdulaEizo TakashimaMasayuki MoritaMiki ShinoharaAkira ShinoharaTakafumi TsuboiToshihiro Horii
Published in: Scientific reports (2018)
The malaria parasite Plasmodium falciparum proliferates in the blood stream where the host immune system is most active. To escape from host immunity, P. falciparum has developed a number of evasion mechanisms. Serine repeat antigen 5 (SERA5) is a blood stage antigen highly expressed at late trophozoite and schizont stages. The P47 N-terminal domain of SERA5, the basis of SE36 antigen of the blood stage vaccine candidate under clinical trials, covers the merozoite surface. Exploring the role of the P47 domain, screening of serum proteins showed that vitronectin (VTN) directly binds to 20 residues in the C-terminal region of SE36. VTN co-localized with P47 domain in the schizont and merozoite stages. Phagocytosis assay using THP-1 cells demonstrated that VTN bound to SE36 prevented engulfment of SE36-beads. In addition, several serum proteins localized on the merozoite surface, suggesting that host proteins camouflage merozoites against host immunity via binding to VTN.
Keyphrases
  • plasmodium falciparum
  • clinical trial
  • induced apoptosis
  • high throughput
  • oxidative stress
  • open label
  • randomized controlled trial
  • phase ii
  • phase iii